These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 11987919

  • 1. Immunological evaluation of minimal residual disease (MRD) in acute myeloid leukaemia (AML).
    San-Miguel JF, Vidriales MB, Orfão A.
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):105-18. PubMed ID: 11987919
    [Abstract] [Full Text] [Related]

  • 2. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T, Babusíková O.
    Neoplasma; 2006 Mar; 53(6):500-6. PubMed ID: 17167719
    [Abstract] [Full Text] [Related]

  • 3. Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.
    Kern W, Danhauser-Riedl S, Ratei R, Schnittger S, Schoch C, Kolb HJ, Ludwig WD, Hiddemann W, Haferlach T.
    Haematologica; 2003 Jun; 88(6):646-53. PubMed ID: 12801840
    [Abstract] [Full Text] [Related]

  • 4. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
    Zelezníková T, Babusíková O.
    Neoplasma; 2005 Jun; 52(6):517-22. PubMed ID: 16284699
    [Abstract] [Full Text] [Related]

  • 5. Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring.
    Langebrake C, Brinkmann I, Teigler-Schlegel A, Creutzig U, Griesinger F, Puhlmann U, Reinhardt D.
    Cytometry B Clin Cytom; 2005 Jan; 63(1):1-9. PubMed ID: 15624201
    [Abstract] [Full Text] [Related]

  • 6. Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
    Campana D, Coustan-Smith E.
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):1-19. PubMed ID: 11987913
    [Abstract] [Full Text] [Related]

  • 7. [Detection of minimal residual disease in patients with acute myeloid leukemia].
    Gal'tseva IV, Savchenko VG, Kulikov SM, Parovichnikova EN, Miterev GIu, Maslova ER, Isaev VG.
    Ter Arkh; 2003 Mar; 75(7):8-14. PubMed ID: 12934474
    [Abstract] [Full Text] [Related]

  • 8. MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia.
    Feller N, van der Pol MA, van Stijn A, Weijers GW, Westra AH, Evertse BW, Ossenkoppele GJ, Schuurhuis GJ.
    Leukemia; 2004 Aug; 18(8):1380-90. PubMed ID: 15201848
    [Abstract] [Full Text] [Related]

  • 9. Minimal residual disease in acute myeloid leukaemia.
    Liu Yin JA.
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):119-35. PubMed ID: 11987920
    [Abstract] [Full Text] [Related]

  • 10. Detection of minimal residual disease in acute leukemia patients.
    van Dongen JJ, Szczepański T, de Bruijn MA, van den Beemd MW, de Bruin-Versteeg S, Wijkhuijs JM, Tibbe GJ, van Gastel-Mol EJ, Groeneveld K, Hooijkaas H.
    Cytokines Mol Ther; 1996 Jun; 2(2):121-33. PubMed ID: 9384697
    [Abstract] [Full Text] [Related]

  • 11. Minimal residual disease monitoring by flow cytometry.
    Vidriales MB, San-Miguel JF, Orfao A, Coustan-Smith E, Campana D.
    Best Pract Res Clin Haematol; 2003 Dec; 16(4):599-612. PubMed ID: 14592645
    [Abstract] [Full Text] [Related]

  • 12. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.
    Al-Mawali A, Gillis D, Lewis I.
    Am J Clin Pathol; 2009 Jan; 131(1):16-26. PubMed ID: 19095561
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of complete disease remission in acute myeloid leukemia: a prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia.
    Bacher U, Kern W, Schoch C, Schnittger S, Hiddemann W, Haferlach T.
    Cancer; 2006 Feb 15; 106(4):839-47. PubMed ID: 16419072
    [Abstract] [Full Text] [Related]

  • 14. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K, Nahajevszky S, Jakab K, Regéczy N, Gopcsa L, László E, Földi J.
    Orv Hetil; 2000 Nov 12; 141(46):2487-92. PubMed ID: 11126681
    [Abstract] [Full Text] [Related]

  • 15. Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients.
    San Miguel JF, Martínez A, Macedo A, Vidriales MB, López-Berges C, González M, Caballero D, García-Marcos MA, Ramos F, Fernández-Calvo J, Calmuntia MJ, Diaz-Mediavilla J, Orfao A.
    Blood; 1997 Sep 15; 90(6):2465-70. PubMed ID: 9310499
    [Abstract] [Full Text] [Related]

  • 16. The role of multiparametric flow cytometry in the detection of minimal residual disease in acute leukaemia.
    Lee D, Grigoriadis G, Westerman D.
    Pathology; 2015 Dec 15; 47(7):609-21. PubMed ID: 26517623
    [Abstract] [Full Text] [Related]

  • 17. Minimal residual disease studies by flow cytometry in acute leukemia.
    Campana D, Coustan-Smith E.
    Acta Haematol; 2004 Dec 15; 112(1-2):8-15. PubMed ID: 15178999
    [Abstract] [Full Text] [Related]

  • 18. New methodologic approaches for immunophenotyping acute leukemias.
    Basso G, Buldini B, De Zen L, Orfao A.
    Haematologica; 2001 Jul 15; 86(7):675-92. PubMed ID: 11454522
    [Abstract] [Full Text] [Related]

  • 19. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov 15; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 20. Monitoring of minimal residual disease in acute myeloid leukemia.
    Buccisano F, Maurillo L, Spagnoli A, Del Principe MI, Ceresoli E, Lo Coco F, Arcese W, Amadori S, Venditti A.
    Curr Opin Oncol; 2009 Nov 15; 21(6):582-8. PubMed ID: 19667983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.